Back
Rhythm Pharmaceuticals Stock Price Chart
32,481% Growth? Meet Mode Mobile's "EarnPhone"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
73
RYTM
Rhythm Pharmaceuticals
Last Price:
53.66
Seasonality Move:
11.04%
7 Day Trial
ALL ACCESS PASS
$
7
Hedge fund manager warns about the market ahead
Free book prepares you for the coming uncertainty in the stock market- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing slight selling pressure.
Rhythm Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 50.55 | Buy |
| 20-day SMA: | 48.38 | Buy |
| 50-day SMA: | 47.86 | Buy |
| 200-day SMA: | 43.39 | Buy |
| 8-day EMA: | 50.8 | Buy |
| 20-day EMA: | 49.06 | Buy |
| 50-day EMA: | 47.17 | Buy |
| 200-day EMA: | 41.51 | Buy |
Rhythm Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.46 | Buy |
| Relative Strength Index (14 RSI): | 67.83 | Buy |
| Chaikin Money Flow: | -159819 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (45.64 - 50.28) | Buy |
| Bollinger Bands (100): | (39.46 - 48.56) | Buy |
Rhythm Pharmaceuticals Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Rhythm Pharmaceuticals Stock
Is Rhythm Pharmaceuticals Stock a Buy?
- Rhythm Pharmaceuticals share price is 53.65 while RYTM 8-day simple moving average is 50.55, which is a Buy signal.
- The stock price of RYTM is 53.65 while Rhythm Pharmaceuticals 20-day SMA is 48.38, which makes it a Buy.
- Rhythm Pharmaceuticals 50-day simple moving average is 47.86 while RYTM share price is 53.65, making it a Buy technically.
- RYTM stock price is 53.65 and Rhythm Pharmaceuticals 200-day simple moving average is 43.39, creating a Buy signal.
RYTM Technical Analysis vs Fundamental Analysis
Buy
73
Rhythm Pharmaceuticals (RYTM)
is a Buy
Is Rhythm Pharmaceuticals a Buy or a Sell?
-
Rhythm Pharmaceuticals stock is rated a Buy
The current Rhythm Pharmaceuticals [RYTM] share price is $53.65. The Score for RYTM is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
Rhythm Pharmaceuticals Stock Info
Market Cap:
3.28B
Price in USD:
53.65
Share Volume:
754.49K
Rhythm Pharmaceuticals 52-Week Range
52-Week High:
54.88
52-Week Low:
20.97
Buy
73
Rhythm Pharmaceuticals (RYTM)
is a Buy
Rhythm Pharmaceuticals Share Price Forecast
-
What is the Rhythm Pharmaceuticals stock price today?
The Rhythm Pharmaceuticals stock price is 53.65 USD today. -
Will RYTM stock go up or go down?
Rhythm Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Rhythm Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Rhythm Pharmaceuticals is not overvalued.
Is Rhythm Pharmaceuticals Stock a Buy?
- Rhythm Pharmaceuticals share price is 53.65 while RYTM 8-day exponential moving average is 50.80, which is a Buy signal.
- The stock price of RYTM is 53.65 while Rhythm Pharmaceuticals 20-day EMA is 49.06, which makes it a Buy.
- Rhythm Pharmaceuticals 50-day exponential moving average is 47.17 while RYTM share price is 53.65, making it a Buy technically.
- RYTM stock price is 53.65 and Rhythm Pharmaceuticals 200-day simple moving average is 41.51, creating a Buy signal.
Fundamental Analysis of Rhythm Pharmaceuticals
Is Rhythm Pharmaceuticals a good investment?
- Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.11 per share, a decrease this year of $1.34 per share, and an increase next year of $1.63 per share.
Technical Analysis of Rhythm Pharmaceuticals
Should I short Rhythm Pharmaceuticals stock?
- RYTM Moving Average Covergence Divergence (MACD) indicator is 1.46, suggesting Rhythm Pharmaceuticals is a Buy
- Rhythm Pharmaceuticals Relative Strength Index (RSI) is 67.83, which suggest Rhythm Pharmaceuticals is overbought
- The Bollinger Bands (25) for Rhythm Pharmaceuticals is (45.64 - 50.28), which suggest Rhythm Pharmaceuticals is a Buy
- The Bollinger Bands (100) for Rhythm Pharmaceuticals is (39.46 - 48.56), which suggest Rhythm Pharmaceuticals is a Buy
* Rhythm Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.